Evidence map›Paper›PMID 42182930›Full record

ArticleMedecine tropicale et sante internationale2026

[Neurological complications of dengue fever in adults at Ouagadougou university hospitals during the 2023 epidemic in Burkina Faso].

Djingri Labodi Lompo, Sylvie D Kagambega, Ouattara Souleymane, Zoungrana Alassane, Melody Zeinab Gnampa, Fabienne Yabtouta Kere, Napon Christian, Millogo Athanase

Abstract readEnglish Abstract
In one paragraph

Article in Medecine tropicale et sante internationale, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Djingri Labodi LompoUniversité Joseph Ki-Zerbo, UFR/SDS, Département de neurologie, Ouagadougou, Burkina Faso.
Sylvie D KagambegaUniversité Joseph Ki-Zerbo, UFR/SDS, Département de neurologie, Ouagadougou, Burkina Faso.
Ouattara SouleymaneUniversité Joseph Ki-Zerbo, UFR/SDS, Département de neurologie, Ouagadougou, Burkina Faso.
Zoungrana AlassaneUniversité Joseph Ki-Zerbo, UFR/SDS, Département de neurologie, Ouagadougou, Burkina Faso.
Melody Zeinab GnampaUniversité Joseph Ki-Zerbo, UFR/SDS, Département de neurologie, Ouagadougou, Burkina Faso.
Fabienne Yabtouta KereUniversité Joseph Ki-Zerbo, UFR/SDS, Département de neurologie, Ouagadougou, Burkina Faso.
Napon ChristianCHU Tengandogo, Service de neurologie, Ouagadougou, Burkina Faso.
Millogo AthanaseUniversité Joseph Ki-Zerbo, UFR/SDS, Département de neurologie, Ouagadougou, Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The most recent dengue epidemic in Burkina Faso in 2023 resulted in the highest morbidity and mortality rates in Africa. Neurological complications of dengue are associated with high mortality rates. This study investigated these complications in adults hospitalized at the Ouagadougou University Hospital during the 2023 dengue epidemic in Burkina Faso. Patients and methods: This cross-sectional, retrospective, descriptive, and analytical study examined confirmed cases of dengue fever in adults hospitalized from January 1 to December 31, 2023, at the University Hospitals of Ouagadougou. We analyzed the frequency of dengue fever-related neurological complications and the sociodemographic, clinical, paraclinical, and intra-hospital data of these patients. A bivariate analysis, followed by a multivariate study using multiple logistic regression, identified factors associated with in-hospital mortality. Results: A total of 1,057 patients were hospitalized with dengue fever in Ouagadougou's university hospitals during the epidemic period. Of these patients, 116 (11%) presented with neurological complications. The mean age of these patients was 47.6 years, and 51.7% were female. The most frequently found neurological clinical signs were impaired consciousness (84.5%), epileptic seizures (20.7%), and psycho-behavioral disorders (14.6%). The neurological complications encountered were encephalopathies (7.8%), probably dengue-related encephalitis (0.8%), strokes (0.7%), and Guillain-Barré syndrome (0.1%). The in-hospital mortality rate was 69% (80 patients), and acute renal failure was the only independent factor associated with it (OR = 3.49; p = 0.02). Conclusion: In Burkina Faso, the neurological complications of dengue are primarily multifactorial encephalopathies, which are associated with a high mortality rate. Screening patients with severe dengue early and admitting them to intensive care or resuscitation units (particularly those with neurological signs) would improve their prognosis.

Indexed as

DengueNervous System DiseasesAdolescentAdultAgedBurkina FasoCross-Sectional StudiesEpidemicsFemaleHospitals, UniversityHumansMaleMiddle AgedRetrospective StudiesYoung AdultBurkina FasoDengueEncephalitisEncephalopathyEpidemicGuillain-Barré syndromeLethalityNeurological complicationsOuagadougouStrokeSub-Saharan Africa

Identifiers

PMID42182930
PMCPMC13196132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.